Kenneth Ludlum

Kenneth E.
Ludlum currently works at Dermavant Sciences, Inc., as Director from 2019, Roivant Sciences, Inc., as Director, Dermavant Sciences Ltd., as Independent Director from 2019, and National Association of Corporate Directors, as Member.
Mr. Ludlum also formerly worked at Revivant Corp., as Chairman, President & Chief Executive Officer from 2002 to 2004, Natus Medical, Inc., as Independent Director, CYTYC Surgical Products, as Director, AtheroMed, Inc., as Director, Personalis, Inc., as Independent Director from 2015 to 2023, Bridgeway Plan for Health, as Director, Thermage, Inc., as Director in 2007, Kinetikos Medical, Inc., as Director, Velomedix, Inc., as Director, CYTYC Surgical Products, as Director, IRIDEX Corp., as Independent Director from 2019 to 2025, DIH Holding US, Inc., as Independent Director from 2024 to 2025, Synvista Therapeutics, Inc., as Chief Financial Officer from 1992 to 1994, Perclose, Inc., as Chief Financial Officer from 1995 to 2000, CareDx, Inc., as Chief Financial & Accounting Officer from 2015 to 2016, Paracor Medical, Inc., as Chief Financial Officer & Senior Vice President, ZONARE Medical Systems, Inc., as Chief Financial Officer & Senior Vice President in 2007, EndoGastric Solutions, Inc., as Chief Financial Officer, VP & Head-Operations from 2011 to 2015, and EndoVasix, Inc., as Vice President-International in 2001.
Mr. Ludlum received his undergraduate degree from Lehigh University and Masters Business Admin degree from Columbia Business School.